FDA Approves Amgen ' s Migraine Drug

The drug ’s list price is $6,900 per year, or $575 per monthly injected dose, lower than many market-watchers expected.

Source: Forbes.com Healthcare News - May 17, 2018 Category: Pharmaceuticals Authors: Ellie Kincaid, Forbes Staff Tags: NASDAQ:AMGN Source Type: news